For example, one of the benefits of IFN treatment for patients with multiple sclerosis is believed to include the induction of IL-10 secretion (60), with IFN additionally increasing the sensitivity of monocytes to IL-10 (61). Here, IFNA1 is linked to multiple sclerosis.